HEGGIE THERESA sold BCRX
August 13, 2025 · Form 4 insider transaction
HEGGIE THERESA sold 70,000 shares of BioCryst Pharmaceuticals, Inc. at $8.51 per share, a transaction worth $595.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
70,000
Price
$8.51
Total value
$595.9K
InsiderHEGGIE THERESA
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2025
Filing dateAugust 15, 2025
Shares owned after65,352
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.48 to $8.55. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.